RELX share price jumps 4.7%: Is LSE: REL’s AI discount unwinding?

RELX PLC (LSE: REL), the global provider of professional information, analytics and decision-support tools, has returned to the FTSE 100 risers list as investors reconsider whether artificial intelligence represents an existential threat or a commercial accelerator for the company. The market snapshot supplied with this article showed RELX shares trading at 2,689 pence, up 4.71%, extending the recovery that followed its first-half results. The company’s Legal and Scientific, Technical and Medical businesses, widely viewed as the divisions most vulnerable to generative artificial intelligence competition, are instead reporting accelerating growth. The central question is whether RELX has supplied enough operating evidence to reverse the deep valuation reset, or whether the latest rally is simply a temporary relief move before the artificial intelligence debate returns.

Why is the RELX share price rising after months of artificial intelligence anxiety?

The immediate recovery coincided with RELX’s first-half results on July 23, 2026. The company reported underlying revenue growth of 7%, underlying adjusted operating-profit growth of 9% and an 11% increase in adjusted earnings per share at constant currencies. RELX also reaffirmed its full-year expectation for strong underlying growth in revenue, adjusted operating profit and adjusted earnings per share.

Although the results-day reaction was volatile, the shares closed 4.77% higher at 2,568 pence on July 24 before extending their recovery in the market snapshot supplied for July 27. Relative to the 2,518-pence closing price recorded on July 20, the shares had risen approximately 6.8%. Compared with the June 26 close of 2,363 pence, the recovery was approximately 13.8%.

That short-term strength must be placed against a much more difficult longer-term chart. The London Stock Exchange reported a 52-week trading range of 1,991 pence to 4,008 pence. At 2,689 pence, RELX remained approximately 33% below the upper end of that range, even after recovering about 35% from the low. The stock therefore remains caught between two competing narratives: a high-quality compounder temporarily mispriced by the market, and an established information provider facing a structural challenge from increasingly capable general-purpose artificial intelligence systems.

The artificial intelligence concern is not imaginary. RELX lost significant market value earlier in 2026 after new artificial intelligence tools intensified fears that legal, research and analytical work could be performed without traditional specialist databases or software platforms. RELX, Thomson Reuters Corporation, Wolters Kluwer N.V. and other professional-information companies were repriced as investors questioned whether artificial intelligence agents could weaken subscription models, reduce licensed-user numbers or place pressure on pricing.

The first-half results did not resolve that debate. They did, however, provide stronger evidence that artificial intelligence adoption is currently helping RELX sell higher-value products rather than visibly displacing its businesses.

What does RELX PLC actually do, and where is its growth coming from?

RELX operates through four principal business areas: Risk, Scientific, Technical and Medical, Legal, and Exhibitions. The company’s competitive position rests on combining proprietary or contributory datasets, specialist content, workflow integration and analytical technology. Its products are used by banks, insurers, governments, lawyers, researchers, doctors and other professionals making decisions where accuracy, traceability and reliability carry financial or legal consequences.

Risk remains the largest division. First-half revenue increased to £1.81 billion, representing underlying growth of 8%, while adjusted operating profit rose to £697 million, an underlying increase of 10%. The division’s adjusted operating margin improved from 37.8% to 38.5%. Growth was supported by financial-crime compliance products, digital fraud and identity solutions, insurance datasets, commodity intelligence and government decision tools.

The Risk division is important because it broadens the investment case beyond scientific publishing and legal research. RELX is not solely dependent on lawyers paying for access to LexisNexis or universities subscribing to Elsevier publications. Fraud detection, identity verification, insurance underwriting and compliance decisions rely on extensive historical and contributory datasets that can be difficult for a new artificial intelligence provider to replicate quickly.

Scientific, Technical and Medical revenue increased 6% on an underlying basis to £1.37 billion, while adjusted operating profit grew 8% to £519 million. Its operating margin increased from 37.1% to 37.9%. RELX attributed the improvement to higher-value analytics and decision tools, strong new sales and products including Scopus AI, Sherpath AI and its research-grade artificial intelligence workspace, LeapSpace.

Legal delivered the strongest divisional growth. Revenue increased 10% on an underlying basis to £959 million, while adjusted operating profit grew 13% to £208 million. The division’s margin improved from 20.9% to 21.7%. RELX said double-digit growth in its law-firm and corporate-legal operations was being supported by adoption of Lexis+ with Protégé, including its agentic legal-assistant capabilities.

This Legal performance matters disproportionately to sentiment. Investors have been concerned that generative artificial intelligence systems could draft, summarise, search and analyse legal documents without requiring traditional research platforms. RELX’s counterargument is that legal professionals need answers grounded in comprehensive, verified and jurisdiction-specific content, rather than responses that are merely plausible. The latest growth figures support that argument, but the durability of this advantage still needs to be demonstrated across several reporting periods.

Did the first-half results genuinely improve the RELX investment case?

RELX generated first-half revenue of £4.87 billion, compared with £4.74 billion a year earlier. Reported growth was 3%, while underlying growth was 7%, reflecting the effects of currencies, disposals, exhibition scheduling and the continuing decline in print-related revenue. Adjusted operating profit reached £1.73 billion, up 9% on an underlying basis, while the adjusted operating margin expanded by 70 basis points to 35.5%.

The margin expansion is significant because it suggests the company is not preserving growth by accepting weaker economics. RELX is investing in new products while continuing to hold cost growth below revenue growth. Adjusted earnings per share increased to 68.6 pence from 63.5 pence, with constant-currency growth of 11%. The interim dividend was increased by 7% to 20.9 pence per share.

Cash generation remained strong, although not flawless. Adjusted cash flow reached £1.69 billion, with cash conversion of 98%. Free cash flow before dividends increased modestly to £1.16 billion, while free cash flow after ordinary dividends was £312 million. Capital expenditure increased to £292 million, including £280 million of capitalised development costs, reflecting continued investment in products and technology.

The combination of rising revenue, faster profit growth, margin expansion and strong cash conversion is consistent with the financial profile investors historically rewarded with a premium valuation. The concern is that past financial resilience does not automatically prove future protection from technological disruption. Artificial intelligence competition may emerge gradually through slower renewals, reduced seat counts, pricing resistance or customers shifting parts of their workflows to alternative platforms.

For that reason, future RELX results will need to show more than group-level growth. Investors will be watching whether Legal and Scientific, Technical and Medical maintain their acceleration, whether adoption translates into durable recurring revenue and whether new artificial intelligence functionality strengthens pricing power rather than becoming a costly feature customers expect to receive without paying substantially more.

How is the market currently valuing RELX PLC after the share-price rebound?

At 2,689 pence, RELX’s implied equity value was approximately £47 billion, based on the latest published market-capitalisation reference adjusted for the higher share price. The London Stock Exchange page listed earnings per share of approximately 113 pence, implying a broad trailing valuation of around 24 times earnings at the supplied price. This should be treated as an indicative reference because reported, adjusted and forward earnings measures can produce materially different valuation multiples.

A valuation near 24 times trailing earnings is not conventionally associated with a company the market expects to enter rapid decline. However, it is materially less demanding than the multiples RELX commanded before the artificial intelligence sell-off. The discount reflects reduced confidence in the duration of its growth rather than evidence that current earnings have collapsed.

This creates an unusual valuation tension. Under a successful-execution scenario, RELX could continue producing mid-to-high-single-digit underlying revenue growth, faster profit growth, improving margins and earnings-per-share support from share repurchases. Under a disruption scenario, even apparently healthy near-term earnings might receive a lower valuation if investors believe future customers will need fewer traditional subscriptions.

The recent rally suggests sentiment has become less negative, but it does not yet demonstrate a full institutional reappraisal. The shares remain far below their 52-week high, and the rebound is only several sessions old. A sustained revaluation would likely require repeated evidence that artificial intelligence products are increasing customer value, expanding usage and protecting renewal economics.

The debate is therefore shifting from whether RELX understands artificial intelligence to whether it can monetise artificial intelligence faster than competitors can use it to weaken established information businesses.

Does RELX’s £2.25 billion share buyback strengthen the valuation case?

RELX announced a £2.25 billion share-buyback programme for 2026. By June 30, it had completed £1.75 billion of repurchases. A further £100 million had been completed after July 1, leaving £400 million expected to be deployed before the end of the year.

The buyback has two possible interpretations. The supportive interpretation is that management considers the shares attractive enough to allocate substantial capital to repurchases while the operating business continues to grow. Reducing the share count can enhance earnings per share and increase the ownership percentage represented by each remaining share.

The more cautious interpretation concerns the balance sheet. Net debt increased from £7.44 billion at June 2025 to £8.73 billion at June 2026, while net debt to earnings before interest, tax, depreciation and amortisation increased from 2.2 times to 2.3 times. The first-half repurchases were much larger than the £312 million of free cash flow remaining after dividends, contributing to the increase in net debt.

This does not indicate an immediate financing crisis. RELX continues to generate substantial recurring cash flow, and its average interest rate on gross debt fell to 3.6% from 4.1%. Nevertheless, the buyback increases the importance of management being correct about the durability of earnings. Repurchasing shares can create attractive returns when the underlying business remains resilient, but it becomes less compelling if long-term growth expectations subsequently weaken.

Investors should therefore judge the buyback alongside operating evidence rather than treating the programme itself as proof that the stock is undervalued.

What could strengthen or weaken the RELX share-price recovery?

The strongest evidence supporting the investment case is the acceleration in the two divisions most associated with artificial intelligence disruption concerns. Legal underlying revenue growth of 10% and Scientific, Technical and Medical growth of 6% indicate that customers are continuing to adopt RELX products even as general-purpose artificial intelligence capabilities expand.

The next requirement is consistency. RELX is scheduled to publish its trading update for the nine months ending September 30 on October 22, 2026. That update will provide the next formal indication of whether Legal, Risk and Scientific, Technical and Medical growth remained strong after the first-half period.

Evidence that would strengthen the case includes continued double-digit or near-double-digit Legal growth, sustained margin expansion, strong renewals, broader use of Lexis+ with Protégé and increasing adoption of Scopus AI, Sherpath AI and LeapSpace. Stable leverage after the unusually large buyback would also reduce concerns about the balance-sheet cost of capital returns.

The thesis would weaken if Legal growth decelerated sharply, if customers began reducing licensed-user numbers, if RELX needed to increase development spending without corresponding revenue gains or if competitors gained traction by combining acceptable accuracy with materially lower prices. A sustained increase in debt without comparable earnings growth would create an additional constraint.

The latest results have improved the evidence supporting RELX’s artificial intelligence strategy. They have not established that the competitive threat has disappeared. The company is currently demonstrating that trusted content, proprietary data and workflow integration retain commercial value. The October update must show that this is a durable operating trend rather than a strong half-year result arriving during an unsettled valuation debate.

What are the key takeaways from the RELX share-price rally and AI debate?

• RELX shares were shown at 2,689 pence, up 4.71%, extending their post-results recovery.
• First-half underlying revenue increased 7%, while underlying adjusted operating profit grew 9%.
• Legal revenue grew 10% and Scientific, Technical and Medical revenue grew 6%, challenging the immediate artificial intelligence disruption narrative.
• Adjusted operating margins improved to 35.5%, while adjusted earnings per share increased 11% at constant currencies.
• RELX is executing a £2.25 billion share buyback, but net debt has increased to £8.73 billion.
• The shares remain approximately 33% below the 52-week high despite the recent rebound.
• The October 22 nine-month trading update is the next measurable test of whether the growth acceleration is sustainable.